Posted, Edited and Photos Added by Valkyrie Extractions Admin
Original Article by Hana Mae Nassar and Martin MacMahon
Adastra Labs in Langley, B.C.
What Does the Dealer’s Licence Permit
“The Dealer’s Licence issued to Adastra Labs does not permit Adastra Labs to sell coca leaf, psilocybin or cocaine to the general public,” the latest release, issued Friday, reads.
Adastra notes that under its Dealer’s Licence, it is only allowed to sell cocaine “to other licensed dealers. Dealers who have cocaine listed on their licence. This includes pharmacists, practitioners, hospitals, or the holder of a section 56(1) exemption for research purposes under the Controlled Drugs and Substances Act (CDSA).”
“The Company is not currently undertaking any activities with cocaine under the Dealer’s Licence. Before doing so, it will only undertake such activities legally permitted by the Dealer’s Licence. After consultation with applicable Provincial Governments,” the statement concludes.
B.C. Premier Expresses Surprise :○
The retraction comes a day after B.C. Premier David Eby expressed surprise that Health Canada had authorized the company to sell cocaine. It had done so without the province’s knowledge.
Eby said he was “astonished” by the announcement when asked about the matter Thursday. He commented a second time Friday. Once again expressing his surprise at Adastra’s announcement.
“I am also wondering what the intention was of Health Canada in granting this licence. Especially to a company that apparently so significantly misrepresented the nature of the licence. As well as in the press release that they issued,” he told reporters.
The Big Cheese Weighs In
As was clarified in Health Canada’s email to CityNews.
“I was as surprised as the premier of British Columbia was to see that a company was talking about selling cocaine on the open market. Or commercializing it. There are limited and very restricted permissions for certain pharmaceutical companies to use that substance. For research purposes and for very specific, narrowly prescribed medical purposes. It is not a permission to sell it commercially. Or provide it on an open market,” the prime minister said Friday.
“We are working very quickly with this company. To correct the misunderstanding that their press release has caused. This is not something that this government is looking at furthering.”
The End Result…
